Global Opioid-Induced Constipation (OIC) Treatment Market Report 2019, Competitive Landscape, Trends and Opportunities
The Opioid-Induced Constipation (OIC) Treatment market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Opioid-Induced Constipation (OIC) Treatment market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Opioid-Induced Constipation (OIC) Treatment market.
Major players in the global Opioid-Induced Constipation (OIC) Treatment market include:
GlaxoSmithKline, Inc.
S.L.A. Pharma AG
Cubist Pharmaceuticals
AIKO Biotechnology
Takeda Pharmaceutical Company Limited
Pfizer, Inc.
Salix Pharmaceuticals, Inc.
AstraZeneca plc, Inc.
On the basis of types, the Opioid-Induced Constipation (OIC) Treatment market is primarily split into:
Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
Non-selective opioid antagonist
?-Opioid antagonist
Locally Acting Chloride Channel Activator (LACCA)
On the basis of applications, the market covers:
Drug store
Independent Pharmacies
Hospital Pharmacies
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Opioid-Induced Constipation (OIC) Treatment market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Opioid-Induced Constipation (OIC) Treatment market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Opioid-Induced Constipation (OIC) Treatment industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Opioid-Induced Constipation (OIC) Treatment market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Opioid-Induced Constipation (OIC) Treatment, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Opioid-Induced Constipation (OIC) Treatment in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Opioid-Induced Constipation (OIC) Treatment in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Opioid-Induced Constipation (OIC) Treatment. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Opioid-Induced Constipation (OIC) Treatment market, including the global production and revenue forecast, regional forecast. It also foresees the Opioid-Induced Constipation (OIC) Treatment market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Opioid-Induced Constipation (OIC) Treatment market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Opioid-Induced Constipation (OIC) Treatment market.
Major players in the global Opioid-Induced Constipation (OIC) Treatment market include:
GlaxoSmithKline, Inc.
S.L.A. Pharma AG
Cubist Pharmaceuticals
AIKO Biotechnology
Takeda Pharmaceutical Company Limited
Pfizer, Inc.
Salix Pharmaceuticals, Inc.
AstraZeneca plc, Inc.
On the basis of types, the Opioid-Induced Constipation (OIC) Treatment market is primarily split into:
Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
Non-selective opioid antagonist
?-Opioid antagonist
Locally Acting Chloride Channel Activator (LACCA)
On the basis of applications, the market covers:
Drug store
Independent Pharmacies
Hospital Pharmacies
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Opioid-Induced Constipation (OIC) Treatment market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Opioid-Induced Constipation (OIC) Treatment market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Opioid-Induced Constipation (OIC) Treatment industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Opioid-Induced Constipation (OIC) Treatment market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Opioid-Induced Constipation (OIC) Treatment, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Opioid-Induced Constipation (OIC) Treatment in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Opioid-Induced Constipation (OIC) Treatment in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Opioid-Induced Constipation (OIC) Treatment. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Opioid-Induced Constipation (OIC) Treatment market, including the global production and revenue forecast, regional forecast. It also foresees the Opioid-Induced Constipation (OIC) Treatment market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Opioid-Induced Constipation (OIC) Treatment
1.2 Opioid-Induced Constipation (OIC) Treatment Segment by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
1.2.3 The Market Profile of Non-selective opioid antagonist
1.2.4 The Market Profile of ?-Opioid antagonist
1.2.5 The Market Profile of Locally Acting Chloride Channel Activator (LACCA)
1.3 Global Opioid-Induced Constipation (OIC) Treatment Segment by Application
1.3.1 Opioid-Induced Constipation (OIC) Treatment Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Drug store
1.3.3 The Market Profile of Independent Pharmacies
1.3.4 The Market Profile of Hospital Pharmacies
1.4 Global Opioid-Induced Constipation (OIC) Treatment Market by Region (2014-2026)
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.1 Germany Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.2 UK Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.3 France Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.4 Italy Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.5 Spain Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.6 Russia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.7 Poland Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.4 China Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.5 Japan Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.6 India Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8 Central and South America Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Opioid-Induced Constipation (OIC) Treatment (2014-2026)
1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue Status and Outlook (2014-2026)
1.5.2 Global Opioid-Induced Constipation (OIC) Treatment Production Status and Outlook (2014-2026)
2 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET LANDSCAPE BY PLAYER
2.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Share by Player (2014-2019)
2.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Player (2014-2019)
2.3 Global Opioid-Induced Constipation (OIC) Treatment Average Price by Player (2014-2019)
2.4 Opioid-Induced Constipation (OIC) Treatment Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Opioid-Induced Constipation (OIC) Treatment Market Competitive Situation and Trends
2.5.1 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate
2.5.2 Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 GlaxoSmithKline, Inc.
3.1.1 GlaxoSmithKline, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.1.3 GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.1.4 GlaxoSmithKline, Inc. Business Overview
3.2 S.L.A. Pharma AG
3.2.1 S.L.A. Pharma AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.2.3 S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.2.4 S.L.A. Pharma AG Business Overview
3.3 Cubist Pharmaceuticals
3.3.1 Cubist Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.3.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.3.4 Cubist Pharmaceuticals Business Overview
3.4 AIKO Biotechnology
3.4.1 AIKO Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.4.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.4.4 AIKO Biotechnology Business Overview
3.5 Takeda Pharmaceutical Company Limited
3.5.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.5.3 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.5.4 Takeda Pharmaceutical Company Limited Business Overview
3.6 Pfizer, Inc.
3.6.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.6.3 Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.6.4 Pfizer, Inc. Business Overview
3.7 Salix Pharmaceuticals, Inc.
3.7.1 Salix Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.7.3 Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.7.4 Salix Pharmaceuticals, Inc. Business Overview
3.8 AstraZeneca plc, Inc.
3.8.1 AstraZeneca plc, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.8.3 AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.8.4 AstraZeneca plc, Inc. Business Overview
4 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Type (2014-2019)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Type (2014-2019)
4.3 Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2014-2019)
4.4 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate by Type (2014-2019)
4.4.1 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2014-2019)
4.4.2 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Non-selective opioid antagonist (2014-2019)
4.4.3 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of ?-Opioid antagonist (2014-2019)
4.4.4 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2014-2019)
5 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET ANALYSIS BY APPLICATION
5.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Market Share by Application (2014-2019)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Drug store (2014-2019)
5.2.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Independent Pharmacies (2014-2019)
5.2.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Hospital Pharmacies (2014-2019)
6 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption by Region (2014-2019)
6.2 United States Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.3 Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.4 China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.5 Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.6 India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
7 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Region (2014-2019)
7.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
8 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MANUFACTURING ANALYSIS
8.1 Opioid-Induced Constipation (OIC) Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Opioid-Induced Constipation (OIC) Treatment
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
9.2 Raw Materials Sources of Opioid-Induced Constipation (OIC) Treatment Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Opioid-Induced Constipation (OIC) Treatment
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET FORECAST (2019-2026)
11.1 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue Forecast (2019-2026)
11.1.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2019-2026)
11.2 Global Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Opioid-Induced Constipation (OIC) Treatment
1.2 Opioid-Induced Constipation (OIC) Treatment Segment by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
1.2.3 The Market Profile of Non-selective opioid antagonist
1.2.4 The Market Profile of ?-Opioid antagonist
1.2.5 The Market Profile of Locally Acting Chloride Channel Activator (LACCA)
1.3 Global Opioid-Induced Constipation (OIC) Treatment Segment by Application
1.3.1 Opioid-Induced Constipation (OIC) Treatment Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Drug store
1.3.3 The Market Profile of Independent Pharmacies
1.3.4 The Market Profile of Hospital Pharmacies
1.4 Global Opioid-Induced Constipation (OIC) Treatment Market by Region (2014-2026)
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.1 Germany Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.2 UK Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.3 France Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.4 Italy Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.5 Spain Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.6 Russia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.3.7 Poland Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.4 China Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.5 Japan Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.6 India Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8 Central and South America Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Opioid-Induced Constipation (OIC) Treatment (2014-2026)
1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue Status and Outlook (2014-2026)
1.5.2 Global Opioid-Induced Constipation (OIC) Treatment Production Status and Outlook (2014-2026)
2 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET LANDSCAPE BY PLAYER
2.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Share by Player (2014-2019)
2.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Player (2014-2019)
2.3 Global Opioid-Induced Constipation (OIC) Treatment Average Price by Player (2014-2019)
2.4 Opioid-Induced Constipation (OIC) Treatment Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Opioid-Induced Constipation (OIC) Treatment Market Competitive Situation and Trends
2.5.1 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate
2.5.2 Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 GlaxoSmithKline, Inc.
3.1.1 GlaxoSmithKline, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.1.3 GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.1.4 GlaxoSmithKline, Inc. Business Overview
3.2 S.L.A. Pharma AG
3.2.1 S.L.A. Pharma AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.2.3 S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.2.4 S.L.A. Pharma AG Business Overview
3.3 Cubist Pharmaceuticals
3.3.1 Cubist Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.3.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.3.4 Cubist Pharmaceuticals Business Overview
3.4 AIKO Biotechnology
3.4.1 AIKO Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.4.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.4.4 AIKO Biotechnology Business Overview
3.5 Takeda Pharmaceutical Company Limited
3.5.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.5.3 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.5.4 Takeda Pharmaceutical Company Limited Business Overview
3.6 Pfizer, Inc.
3.6.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.6.3 Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.6.4 Pfizer, Inc. Business Overview
3.7 Salix Pharmaceuticals, Inc.
3.7.1 Salix Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.7.3 Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.7.4 Salix Pharmaceuticals, Inc. Business Overview
3.8 AstraZeneca plc, Inc.
3.8.1 AstraZeneca plc, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
3.8.3 AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Market Performance (2014-2019)
3.8.4 AstraZeneca plc, Inc. Business Overview
4 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Type (2014-2019)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Type (2014-2019)
4.3 Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2014-2019)
4.4 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate by Type (2014-2019)
4.4.1 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2014-2019)
4.4.2 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Non-selective opioid antagonist (2014-2019)
4.4.3 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of ?-Opioid antagonist (2014-2019)
4.4.4 Global Opioid-Induced Constipation (OIC) Treatment Production Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2014-2019)
5 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET ANALYSIS BY APPLICATION
5.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Market Share by Application (2014-2019)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Drug store (2014-2019)
5.2.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Independent Pharmacies (2014-2019)
5.2.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate of Hospital Pharmacies (2014-2019)
6 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption by Region (2014-2019)
6.2 United States Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.3 Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.4 China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.5 Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.6 India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import (2014-2019)
7 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Region (2014-2019)
7.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
8 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MANUFACTURING ANALYSIS
8.1 Opioid-Induced Constipation (OIC) Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Opioid-Induced Constipation (OIC) Treatment
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
9.2 Raw Materials Sources of Opioid-Induced Constipation (OIC) Treatment Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Opioid-Induced Constipation (OIC) Treatment
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET FORECAST (2019-2026)
11.1 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue Forecast (2019-2026)
11.1.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2019-2026)
11.2 Global Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
